CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- 4 Shares withheld for taxes Chief Financial Officer gave up 792 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Director sold 1,002 shares at $2.38 ($2,385)
- 4 Shares withheld for taxes SVP, General Counsel gave up 207 shares (to pay taxes)
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- EFFECT Other Notice of Effectiveness
- 4 Open-market buy SVP, General Counsel bought 5,869 shares at $3.13 ($18,370)
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 4 Open-market buy Chief Financial Officer bought 2,500 shares at $4.00 ($10,000)
- 4 Open-market buy SVP, General Counsel bought 7,500 shares at $3.99 ($29,925)
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
Page 18 of 66 · 1,318 filings